Stay updated on Deucravacitinib in Active Psoriatic Arthritis: Clinical Trial
Sign up to get notified when there's something new on the Deucravacitinib in Active Psoriatic Arthritis: Clinical Trial page.
![Latest website image capture](/pages/_next/image?url=https%3A%2F%2Fs3.us-west-2.amazonaws.com%2Fvp-files-ore%2Fresources%2F12months%2F_1VEX2PYo6YG_tEOn-aZVvRgtr0.uncropped.jpg&w=3840&q=75)
Latest updates to the Deucravacitinib in Active Psoriatic Arthritis: Clinical Trial page
- CheckyesterdayChange DetectedThe website has been updated from version 2.10.2 to 2.10.3.SummaryDifference0.1%
- Check9 days agoChange DetectedThe website has added new content, while the FDA Safety Alerts and Recalls section has been removed.SummaryDifference0.1%
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe website has been updated from version 2.10.0 to 2.10.2, indicating new features or improvements.SummaryDifference0.0%
- Check30 days agoNo Change Detected
- Check45 days agoChange DetectedThe study has expanded to include 187 locations, and the website has been updated to version 2.10.0, replacing the previous version 2.9.7.SummaryDifference0.2%
- Check51 days agoChange DetectedThe website has been updated to Revision v2.9.7 from v2.9.6.SummaryDifference0.1%
- Check65 days agoChange DetectedThe value of Revision has been updated from v2.9.5 to v2.9.6, indicating a recent revision in the content of the web page.SummaryDifference0.1%
Stay in the know with updates to Deucravacitinib in Active Psoriatic Arthritis: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Deucravacitinib in Active Psoriatic Arthritis: Clinical Trial page.